Summary of the Conference Call for Hangzhou Minsheng Health Pharmaceutical Co., Ltd. Company Overview - Hangzhou Minsheng Health Pharmaceutical Co., Ltd. focuses on the health sector, specializing in the research, production, and sales of vitamins, minerals, and other over-the-counter health food products [1] Financial Performance - For the fiscal year 2024, the company reported a revenue of 641 million yuan, representing a year-on-year increase of 10.23% [1] - The net profit attributable to shareholders was 91.83 million yuan, reflecting a growth of 7.24% compared to the previous year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 87.21 million yuan, which is a 10.13% increase year-on-year [1] Strategic Initiatives - The company aims to enhance product innovation and research by focusing on new products, new business models, and new projects as part of its core strategy for 2024 [2] - There is an emphasis on expanding the product matrix in the OTC health food sector, particularly in micro-mineral and other categories [2] Business Development - The company achieved a 15.7% increase in net profit for the first quarter of 2024, amounting to 6.3 million yuan, with a 6.5% growth compared to the same period last year [3] - The launch of the carbonic enzyme mixed solution in the OTC sector is highlighted as a significant achievement [3] - Strategic partnerships in the medical field are being pursued to accelerate growth and enhance resource integration [3] - New health brands, such as Minsheng Tongchun Medical Aesthetics, are being introduced alongside existing product lines [3] Future Outlook - The company plans to continue leveraging its "Four New" strategy to deepen its focus on micro-mineral therapeutic OTC medications and accelerate the launch of new products [4] - There is a commitment to continuously improve the product pipeline to support rapid growth in performance [4] - The management expresses a desire for feedback from investors and stakeholders to further enhance company operations [4]